Cargando…

Serum Angiopoietin-1 and -2 Levels Discriminate Cerebral Malaria from Uncomplicated Malaria and Predict Clinical Outcome in African Children

BACKGROUND: Limited tools exist to identify which individuals infected with Plasmodium falciparum are at risk of developing serious complications such as cerebral malaria (CM). The objective of this study was to assess serum biomarkers that differentiate between CM and non-CM, with the long-term goa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lovegrove, Fiona E., Tangpukdee, Noppadon, Opoka, Robert O., Lafferty, Erin I., Rajwans, Nimerta, Hawkes, Michael, Krudsood, Srivicha, Looareesuwan, Sornchai, John, Chandy C., Liles, W. Conrad, Kain, Kevin C.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2657207/
https://www.ncbi.nlm.nih.gov/pubmed/19300530
http://dx.doi.org/10.1371/journal.pone.0004912
_version_ 1782165570073919488
author Lovegrove, Fiona E.
Tangpukdee, Noppadon
Opoka, Robert O.
Lafferty, Erin I.
Rajwans, Nimerta
Hawkes, Michael
Krudsood, Srivicha
Looareesuwan, Sornchai
John, Chandy C.
Liles, W. Conrad
Kain, Kevin C.
author_facet Lovegrove, Fiona E.
Tangpukdee, Noppadon
Opoka, Robert O.
Lafferty, Erin I.
Rajwans, Nimerta
Hawkes, Michael
Krudsood, Srivicha
Looareesuwan, Sornchai
John, Chandy C.
Liles, W. Conrad
Kain, Kevin C.
author_sort Lovegrove, Fiona E.
collection PubMed
description BACKGROUND: Limited tools exist to identify which individuals infected with Plasmodium falciparum are at risk of developing serious complications such as cerebral malaria (CM). The objective of this study was to assess serum biomarkers that differentiate between CM and non-CM, with the long-term goal of developing a clinically informative prognostic test for severe malaria. METHODOLOGY/PRINCIPAL FINDINGS: Based on the hypothesis that endothelial activation and blood-brain-barrier dysfunction contribute to CM pathogenesis, we examined the endothelial regulators, angiopoietin-1 (ANG-1) and angiopoietin-2 (ANG-2), in serum samples from P. falciparum-infected patients with uncomplicated malaria (UM) or CM, from two diverse populations – Thai adults and Ugandan children. Angiopoietin levels were compared to tumour necrosis factor (TNF). In both populations, ANG-1 levels were significantly decreased and ANG-2 levels were significantly increased in CM versus UM and healthy controls (p<0.001). TNF was significantly elevated in CM in the Thai adult population (p<0.001), but did not discriminate well between CM and UM in African children. Receiver operating characteristic curve analysis showed that ANG-1 and the ratio of ANG-2∶ANG-1 accurately discriminated CM patients from UM in both populations. Applied as a diagnostic test, ANG-1 had a sensitivity and specificity of 100% for distinguishing CM from UM in Thai adults and 70% and 75%, respectively, for Ugandan children. Across both populations the likelihood ratio of CM given a positive test (ANG-1<15 ng/mL) was 4.1 (2.7–6.5) and the likelihood ratio of CM given a negative test was 0.29 (0.20–0.42). Moreover, low ANG-1 levels at presentation predicted subsequent mortality in children with CM (p = 0.027). CONCLUSIONS/SIGNIFICANCE: ANG-1 and the ANG-2/1 ratio are promising clinically informative biomarkers for CM. Additional studies should address their utility as prognostic biomarkers and potential therapeutic targets in severe malaria.
format Text
id pubmed-2657207
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-26572072009-03-20 Serum Angiopoietin-1 and -2 Levels Discriminate Cerebral Malaria from Uncomplicated Malaria and Predict Clinical Outcome in African Children Lovegrove, Fiona E. Tangpukdee, Noppadon Opoka, Robert O. Lafferty, Erin I. Rajwans, Nimerta Hawkes, Michael Krudsood, Srivicha Looareesuwan, Sornchai John, Chandy C. Liles, W. Conrad Kain, Kevin C. PLoS One Research Article BACKGROUND: Limited tools exist to identify which individuals infected with Plasmodium falciparum are at risk of developing serious complications such as cerebral malaria (CM). The objective of this study was to assess serum biomarkers that differentiate between CM and non-CM, with the long-term goal of developing a clinically informative prognostic test for severe malaria. METHODOLOGY/PRINCIPAL FINDINGS: Based on the hypothesis that endothelial activation and blood-brain-barrier dysfunction contribute to CM pathogenesis, we examined the endothelial regulators, angiopoietin-1 (ANG-1) and angiopoietin-2 (ANG-2), in serum samples from P. falciparum-infected patients with uncomplicated malaria (UM) or CM, from two diverse populations – Thai adults and Ugandan children. Angiopoietin levels were compared to tumour necrosis factor (TNF). In both populations, ANG-1 levels were significantly decreased and ANG-2 levels were significantly increased in CM versus UM and healthy controls (p<0.001). TNF was significantly elevated in CM in the Thai adult population (p<0.001), but did not discriminate well between CM and UM in African children. Receiver operating characteristic curve analysis showed that ANG-1 and the ratio of ANG-2∶ANG-1 accurately discriminated CM patients from UM in both populations. Applied as a diagnostic test, ANG-1 had a sensitivity and specificity of 100% for distinguishing CM from UM in Thai adults and 70% and 75%, respectively, for Ugandan children. Across both populations the likelihood ratio of CM given a positive test (ANG-1<15 ng/mL) was 4.1 (2.7–6.5) and the likelihood ratio of CM given a negative test was 0.29 (0.20–0.42). Moreover, low ANG-1 levels at presentation predicted subsequent mortality in children with CM (p = 0.027). CONCLUSIONS/SIGNIFICANCE: ANG-1 and the ANG-2/1 ratio are promising clinically informative biomarkers for CM. Additional studies should address their utility as prognostic biomarkers and potential therapeutic targets in severe malaria. Public Library of Science 2009-03-20 /pmc/articles/PMC2657207/ /pubmed/19300530 http://dx.doi.org/10.1371/journal.pone.0004912 Text en Lovegrove et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Lovegrove, Fiona E.
Tangpukdee, Noppadon
Opoka, Robert O.
Lafferty, Erin I.
Rajwans, Nimerta
Hawkes, Michael
Krudsood, Srivicha
Looareesuwan, Sornchai
John, Chandy C.
Liles, W. Conrad
Kain, Kevin C.
Serum Angiopoietin-1 and -2 Levels Discriminate Cerebral Malaria from Uncomplicated Malaria and Predict Clinical Outcome in African Children
title Serum Angiopoietin-1 and -2 Levels Discriminate Cerebral Malaria from Uncomplicated Malaria and Predict Clinical Outcome in African Children
title_full Serum Angiopoietin-1 and -2 Levels Discriminate Cerebral Malaria from Uncomplicated Malaria and Predict Clinical Outcome in African Children
title_fullStr Serum Angiopoietin-1 and -2 Levels Discriminate Cerebral Malaria from Uncomplicated Malaria and Predict Clinical Outcome in African Children
title_full_unstemmed Serum Angiopoietin-1 and -2 Levels Discriminate Cerebral Malaria from Uncomplicated Malaria and Predict Clinical Outcome in African Children
title_short Serum Angiopoietin-1 and -2 Levels Discriminate Cerebral Malaria from Uncomplicated Malaria and Predict Clinical Outcome in African Children
title_sort serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in african children
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2657207/
https://www.ncbi.nlm.nih.gov/pubmed/19300530
http://dx.doi.org/10.1371/journal.pone.0004912
work_keys_str_mv AT lovegrovefionae serumangiopoietin1and2levelsdiscriminatecerebralmalariafromuncomplicatedmalariaandpredictclinicaloutcomeinafricanchildren
AT tangpukdeenoppadon serumangiopoietin1and2levelsdiscriminatecerebralmalariafromuncomplicatedmalariaandpredictclinicaloutcomeinafricanchildren
AT opokaroberto serumangiopoietin1and2levelsdiscriminatecerebralmalariafromuncomplicatedmalariaandpredictclinicaloutcomeinafricanchildren
AT laffertyerini serumangiopoietin1and2levelsdiscriminatecerebralmalariafromuncomplicatedmalariaandpredictclinicaloutcomeinafricanchildren
AT rajwansnimerta serumangiopoietin1and2levelsdiscriminatecerebralmalariafromuncomplicatedmalariaandpredictclinicaloutcomeinafricanchildren
AT hawkesmichael serumangiopoietin1and2levelsdiscriminatecerebralmalariafromuncomplicatedmalariaandpredictclinicaloutcomeinafricanchildren
AT krudsoodsrivicha serumangiopoietin1and2levelsdiscriminatecerebralmalariafromuncomplicatedmalariaandpredictclinicaloutcomeinafricanchildren
AT looareesuwansornchai serumangiopoietin1and2levelsdiscriminatecerebralmalariafromuncomplicatedmalariaandpredictclinicaloutcomeinafricanchildren
AT johnchandyc serumangiopoietin1and2levelsdiscriminatecerebralmalariafromuncomplicatedmalariaandpredictclinicaloutcomeinafricanchildren
AT lileswconrad serumangiopoietin1and2levelsdiscriminatecerebralmalariafromuncomplicatedmalariaandpredictclinicaloutcomeinafricanchildren
AT kainkevinc serumangiopoietin1and2levelsdiscriminatecerebralmalariafromuncomplicatedmalariaandpredictclinicaloutcomeinafricanchildren